Advanced glycosylation end product-specific receptor
| GO Term | Evidence Code | Reference |
|---|---|---|
| response to hypoxia | ||
| microglial cell activation | ||
| microglial cell activation | ||
| regulation of T cell mediated cytotoxicity | ||
| negative regulation of endothelial cell proliferation |
| GO Term | Evidence Code | Reference |
|---|---|---|
| fibrillar center |
|
|
| phagocytic cup | ||
| phagocytic cup | ||
| phagocytic cup | ||
| extracellular region |
| GO Term | Evidence Code | Reference |
|---|---|---|
| amyloid-beta binding | ||
| DNA binding | ||
| DNA binding | ||
| RNA binding | ||
| RNA binding |
| Pathway Name | Organism |
|---|---|
| Advanced glycosylation endproduct receptor signaling | Rattus norvegicus |
| TAK1-dependent IKK and NF-kappa-B activation | Rattus norvegicus |
| TRAF6 mediated NF-kB activation | Rattus norvegicus |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050855 | renal fibrosis | |
| DOID:12918 | thromboangiitis obliterans | |
| DOID:77 | gastrointestinal system disease | |
| DOID:1875 | impotence | |
| DOID:8947 | diabetic retinopathy | |
| DOID:9352 | type 2 diabetes mellitus | |
| DOID:2841 | asthma | |
| DOID:10652 | Alzheimer's disease |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026